SARAH SOUFFRANT: Open Payments
NPI 1134746233 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,762 in 95 payments from 18 companies in 2025. Trend: 2023 $151 · 2024 $238 · 2025 $1,762
Food & beverage: $1,762
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 25 | $538 |
| ABBVIE INC. | 21 | $211 |
| Lundbeck LLC | 14 | $177 |
| LivaNova USA, Inc. | 6 | $150 |
| Alexion Pharmaceuticals, Inc. | 3 | $94 |
| JAZZ PHARMACEUTICALS INC. | 4 | $80 |
| ACADIA Pharmaceuticals Inc | 4 | $79 |
| PFIZER INC. | 3 | $79 |
| Teva Pharmaceuticals USA, Inc. | 3 | $77 |
| Janssen Biotech, Inc. | 2 | $51 |
Products named: Fintepla, Briviact, VYEPTI, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, UBRELVY, ULTOMIRIS, QULIPTA, EPIDIOLEX.
Industry payments across TX — which companies pay providers there.
